FORM 10-K

Company

REVIVA PHARMACEUTICALS HOLDINGS, INC.

Filed

March 30, 2023

Period of Report

December 31, 2022

Accession Number

0001437749-23-008502

A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →